Genetic Risk Marker Found for Depression
the Psychiatry Advisor take:
A genetic variant known to be connected to an increased risk for developing Alzheimer’s disease may also be associated with an elevated risk of late-life depression.
Silke Kern, PhD, of the University of Gothenburg, Sweden, and colleagues looked at the relationship between the epsilon 4 (ε4) allele of the apolipoprotein gene (APOE) and depression in 839 older Swedish adults who were followed for more than five years.
The APOE ε4 allele correctly predicted future depression, even after excluding people who later developed dementia, the researchers reported in the journal Biological Psychiatry. Among subjects without depression at study entry and without dementia or significant cognitive decline during the subsequent nine years, APOE ε4 was prospectively associated with more severe depressive symptoms, incident minor depression, and any depression.
“APOE ε4 might be a marker for identifying older persons at risk to develop depression or dementia, which could be important for prevention and early detection of these common disorders,” Kern said in a statement.
APOE ε4 has also been associated with atherosclerosis as well as cardiovascular and cerebrovascular disease.
The APOE ε4 allele correctly predicted future depression, even after excluding people who later developed dementia.
One of the most powerful predictors in neuropsychiatry is the epsilon 4 (ε4) allele of the apolipoprotein gene (APOE).
Individuals who carry this ε4 variant of APOE are at increased risk for developing Alzheimer's disease, early age of Alzheimer's disease onset, and more rapid progression of Alzheimer's disease symptoms. APOE ε4 has also been associated with atherosclerosis as well as cardiovascular and cerebrovascular disease.
A new study published in the current issue of Biological Psychiatry suggests that even when controlling for the risk for Alzheimer's disease, the APOE ε4 allele also conveys an increased risk for late-life depression.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Obstructive Sleep Apnea Treatment Prevents Progression of Subclinical PTSD in Veterans
- Managing Comorbid Bipolar Disorder and Alcohol Use Disorder: Clinical Challenges and Conundrums
- Intranasal Esketamine for MDD: Exploring Alternative Options for Treatment-Resistant Depression
- Physician Salaries and Rising Health Care Costs: Is There an Association?
- Autism Spectrum Disorder Prevalence Among Children, Adolescents in United States
- Pregnancy and Bipolar Disorder: Expert Interview With Leena Mittal, MD
- Statistical vs Clinical Significance: Evaluating Bias in Research
- Preventing Suicide in Prison Inmates
- Lurasidone Monotherapy Safe, Efficacious in Children, Adolescents With Bipolar Depression
- Sleep Disruption May Lead to Increased Beta Amyloid Production
- Anhedonia and Suicidal Ideation Linked Independent of Major Affective Disorders
- Neuroticism and Polygenic Depression Risk Increase Risk for Major Depressive Disorder
- Varenicline Reduces Heavy Drinking, Cigarette Smoking in Men With Alcohol Use Disorder
- Monitoring Symptom Fluctuations Can Help Predict Depression Relapse, Recurrence
- High BMI Associated With Increased Risk of Dementia